Business Context and Reporting Period
Company: American Shared Hospital Services (AMS)
Filing Type: Form 8-K (Current Report)
Report Date: December 17, 2024 (Events reported through December 19, 2024)
Context: The filing discloses a material amendment to the company's credit agreement, the resignation and replacement of the Chief Financial Officer, and the receipt of a regulatory certificate for a new radiation treatment system.
Key Financial Metrics and Obligations
This filing does not contain standard financial statements (revenue, profit, or cash flow). Key financial data points disclosed include:
- New Debt: $7.0 million Second Supplemental Term Loan.
- Debt Maturity: December 18, 2029.
- Liquidity Covenant: Requirement to maintain at least $5,000,000 of unrestricted cash.
- Executive Compensation (New CFO): $275,000 annual base salary, ~$30,000 sign-on bonus, 30% performance bonus eligibility, and 50,000 restricted stock units (RSUs).
- Executive Severance (Outgoing CFO): Bi-weekly gross sum of $9,230.77 until April 25, 2025, plus up to 18 months of COBRA health coverage.
Material Changes and Events
Debt Financing
The Company entered into a Second Amendment to its Credit Agreement with Fifth Third Bank. This added a $7.0 million term loan to finance the acquisition of 60% of Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC (acquired May 2024), along with related transaction costs and capital expenditures. The loan is secured by a lien on substantially all assets.
Executive Leadership Changes
Robert Hiatt resigned as Chief Financial Officer effective December 19, 2024, with a transition period through January 31, 2025. R. Scott Frech was appointed as the new Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer effective immediately.
Regulatory Approval
The Company received a Certificate of Need to acquire technology for a freestanding proton beam radiation treatment system in Johnston, Rhode Island.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or outlook. However, it notes the following operational and financial developments:
- Covenant Modifications: The fixed charge coverage ratio definition was modified to reduce EBITDA by maintenance capital expenditures rather than total capital expenditures.
- Strategic Expansion: The receipt of the Certificate of Need indicates progress in expanding radiation therapy capabilities in Rhode Island.
- Management Continuity: The appointment of a new CFO with significant experience in healthcare finance and managed care suggests a focus on operational strategy and financial modeling.
Investor Verification Checklist
- Verify the full terms of the Second Amendment to the Credit Agreement (Exhibit 10.1) to understand all covenants and default provisions.
- Confirm the integration timeline and financial impact of the Rhode Island cancer center acquisition.
- Monitor the transition of financial reporting responsibilities from the outgoing to the incoming CFO.
- Review the press release (Exhibit 99.1) for details on the timeline and capital requirements for the new proton beam facility.
- Assess the impact of the new $7.0 million debt obligation on the company's leverage ratios and interest coverage.